Collectively, these studies suggest IgA deficiency is associated with increased intestinal inflammation, microbial dysbiosis, and increased susceptibility to CRC, with potential avenues of IgA monoclonal antibody therapy in CRC. This evidence concerns the gene CD79A and hyperinsulinemic hypoglycemia, familial, 4.